Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
27/04/2026 02:36
April 27 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX: COMPLETES A$14.0 MILLION PLACEMENT PLACEMENT AT AN ISSUE PRICE OF A$0.19 PER SHARE Further company coverage: PAR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt